• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fusobacterium nucleatum IgA 和 IgG ELISA 检测在结直肠癌中的诊断准确性。

Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer.

机构信息

Department of Medical Microbiology, Kocaeli University Faculty of Medicine, 41380, Kocaeli, Turkey.

出版信息

Sci Rep. 2021 Jan 15;11(1):1608. doi: 10.1038/s41598-021-81171-1.

DOI:10.1038/s41598-021-81171-1
PMID:33452405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7811007/
Abstract

The colorectal cancer is a serious health problem. The diagnosis of the disease mostly relies on an invasive procedure. A non-invasive diagnostic test such as an immunoassay, may facilitate diagnosis of colorectal cancer. The purpose of the study was to evaluate the use of antibodies against Fusobacterium nucleatum in the diagnosis of colorectal cancer (CRC). Totally 78 patients in three groups were included in the study. F. nucleatum in the tissues was detected using quantitative polymerase chain reaction assay. F. nucleatum IgA and IgG were measured using enzyme linked immunosorbent assay. F. nucleatum was detected in 86.7% and 73.1% cases of CRC and precancerous-benign colon disease (P-BCD), respectively. The OD values from F. nucleatum IgA and IgG ELISA tests were higher in CRC group compared with healthy individuals. The sensitivity of IgA ELISA test varied between 31.8 and 95.5% depending on the chosen cut-off values. The positivity rate of antibodies in patients with high amount of F. nucleatum in tissue was significantly greater than in the negative group. The F. nucleatum IgA and IgG antibodies in CRC were higher than the ones in healthy controls but the discriminative ability of the ELISA test was not adequate to be considered as a diagnostic tool.

摘要

结直肠癌是一个严重的健康问题。该疾病的诊断主要依赖于一种有创性的程序。一种非侵入性的诊断测试,如免疫测定,可能有助于结直肠癌的诊断。本研究旨在评估抗具核梭杆菌抗体在结直肠癌(CRC)诊断中的应用。共有 78 例患者分为三组纳入本研究。使用定量聚合酶链反应检测组织中的具核梭杆菌。使用酶联免疫吸附试验检测具核梭杆菌 IgA 和 IgG。在 CRC 和癌前良性结肠疾病(P-BCD)病例中分别检测到 86.7%和 73.1%的具核梭杆菌。与健康个体相比,CRC 组的具核梭杆菌 IgA 和 IgG ELISA 试验的 OD 值更高。根据所选的截断值,IgA ELISA 试验的灵敏度在 31.8%至 95.5%之间变化。组织中具核梭杆菌含量高的患者的抗体阳性率明显高于阴性组。CRC 中的具核梭杆菌 IgA 和 IgG 抗体高于健康对照组,但 ELISA 试验的鉴别能力不足,不能作为诊断工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/2d41d2908830/41598_2021_81171_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/cf29d491dd7c/41598_2021_81171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/e0de246dceee/41598_2021_81171_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/2d41d2908830/41598_2021_81171_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/cf29d491dd7c/41598_2021_81171_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/e0de246dceee/41598_2021_81171_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b119/7811007/2d41d2908830/41598_2021_81171_Fig3_HTML.jpg

相似文献

1
Diagnostic accuracy of Fusobacterium nucleatum IgA and IgG ELISA test in colorectal cancer.Fusobacterium nucleatum IgA 和 IgG ELISA 检测在结直肠癌中的诊断准确性。
Sci Rep. 2021 Jan 15;11(1):1608. doi: 10.1038/s41598-021-81171-1.
2
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.具核梭杆菌与结直肠癌中的 T 细胞
JAMA Oncol. 2015 Aug;1(5):653-61. doi: 10.1001/jamaoncol.2015.1377.
3
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.具核梭杆菌肿瘤 DNA 水平与结直肠癌患者的生存相关。
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1891-1899. doi: 10.1007/s10096-019-03649-1. Epub 2019 Jul 31.
4
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.具核梭杆菌通过激活Toll样受体4信号传导至核因子κB并上调微小RNA-21的表达来增加结肠直肠癌细胞的增殖和小鼠肿瘤的发展。
Gastroenterology. 2017 Mar;152(4):851-866.e24. doi: 10.1053/j.gastro.2016.11.018. Epub 2016 Nov 19.
5
The Role of Fecal and as Early Diagnostic Markers of Colorectal Cancer.粪便 和 的作用:结直肠癌的早期诊断标志物。
Dis Markers. 2021 Nov 22;2021:1171239. doi: 10.1155/2021/1171239. eCollection 2021.
6
Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.检测挪威结直肠癌患者粪便和结肠组织中的具核梭杆菌。
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1367-1376. doi: 10.1007/s10096-019-03562-7. Epub 2019 Apr 25.
7
[Analysis using ELISA test of antibody response to Fusobacterium nucleatum and Eikenella corrodens in subjects with periodontal disease].[对牙周病患者针对具核梭杆菌和腐蚀艾肯菌抗体反应的ELISA检测分析]
Med Clin (Barc). 2000 Jul 1;115(5):176-7. doi: 10.1016/s0025-7753(00)71499-0.
8
Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.具核梭杆菌感染与中国患者结直肠癌的关联
World J Gastroenterol. 2016 Mar 21;22(11):3227-33. doi: 10.3748/wjg.v22.i11.3227.
9
Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.具核梭杆菌作为日本人群结直肠癌的预后标志物。
J Gastroenterol. 2018 Apr;53(4):517-524. doi: 10.1007/s00535-017-1382-6. Epub 2017 Aug 19.
10
Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.以具核梭杆菌为标志物的高灵敏度粪便DNA检测用于日本人群结直肠肿瘤的检测
Ann Clin Biochem. 2017 Jan;54(1):86-91. doi: 10.1177/0004563216643970. Epub 2016 Sep 28.

引用本文的文献

1
Association of with colorectal cancer molecular subtypes and its outcome: a systematic review.[具体因素]与结直肠癌分子亚型的关联及其预后:一项系统综述。 (这里原文中“Association of with”缺少具体内容,翻译时添加了“[具体因素]”来使句子完整)
Gut Microbiome (Camb). 2025 Apr 8;6:e5. doi: 10.1017/gmb.2025.3. eCollection 2025.
2
Gut microbiota dysbiosis and associated immune response in systemic lupus erythematosus: impact of disease and treatment.系统性红斑狼疮中的肠道微生物群失调及相关免疫反应:疾病与治疗的影响
Gut Pathog. 2025 Feb 18;17(1):10. doi: 10.1186/s13099-025-00683-7.
3
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.

本文引用的文献

1
Correction to: Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.对《挪威结直肠癌患者粪便和结肠组织中具核梭杆菌的检测》一文的更正
Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):213. doi: 10.1007/s10096-019-03712-x.
2
Microbiome Dysbiosis and Predominant Bacterial Species as Human Cancer Biomarkers.微生物群失调与主要细菌种类作为人类癌症生物标志物
J Gastrointest Cancer. 2020 Sep;51(3):725-728. doi: 10.1007/s12029-019-00311-z.
3
Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
结直肠癌患者中具核梭杆菌和脆弱拟杆菌的全球患病率:病例报告/病例系列概述及患病率研究的荟萃分析
BMC Gastroenterol. 2025 Feb 10;25(1):71. doi: 10.1186/s12876-025-03664-x.
4
Application of as a biomarker in gastrointestinal malignancies.作为生物标志物在胃肠道恶性肿瘤中的应用。
World J Gastrointest Oncol. 2024 Jun 15;16(6):2271-2283. doi: 10.4251/wjgo.v16.i6.2271.
5
Immunomagnetic-bead enriched culturomics (IMBEC) for isolating pathobionts from feces of colorectal cancer patients.用于从结直肠癌患者粪便中分离致病共生菌的免疫磁珠富集培养组学(IMBEC)
Imeta. 2023 Apr 5;2(2):e100. doi: 10.1002/imt2.100. eCollection 2023 May.
6
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance.具核梭杆菌在肿瘤中的作用:从肿瘤发生到肿瘤转移和肿瘤耐药。
Cancer Biol Ther. 2024 Dec 31;25(1):2306676. doi: 10.1080/15384047.2024.2306676. Epub 2024 Jan 30.
7
Novel six-gene prognostic signature based on colon adenocarcinoma immune-related genes.基于结肠腺癌免疫相关基因的新型六基因预后签名。
BMC Bioinformatics. 2022 Oct 11;23(1):418. doi: 10.1186/s12859-022-04909-2.
8
Fusobacterium nucleatum and cancer.具核梭杆菌与癌症。
Periodontol 2000. 2022 Jun;89(1):166-180. doi: 10.1111/prd.12426. Epub 2022 Mar 4.
9
AVL9 promotes colorectal carcinoma cell migration via regulating EGFR expression.AVL9通过调节表皮生长因子受体(EGFR)的表达促进结肠癌细胞迁移。
Biol Proced Online. 2022 Jan 6;24(1):1. doi: 10.1186/s12575-021-00162-8.
10
Bacterial and Parasitic Pathogens as Risk Factors for Cancers in the Gastrointestinal Tract: A Review of Current Epidemiological Knowledge.胃肠道癌症危险因素之细菌和寄生虫病原体:当前流行病学知识综述
Front Microbiol. 2021 Dec 8;12:790256. doi: 10.3389/fmicb.2021.790256. eCollection 2021.
结直肠癌中的肠道微生物群:作用机制和临床应用。
Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):690-704. doi: 10.1038/s41575-019-0209-8. Epub 2019 Sep 25.
4
Antibody Responses to Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.在诊断前的血液样本中针对蛋白质的抗体反应与结直肠癌发病风险无关。
Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1552-1555. doi: 10.1158/1055-9965.EPI-19-0313.
5
-positive colorectal cancer.阳性结直肠癌
Oncol Lett. 2019 Aug;18(2):975-982. doi: 10.3892/ol.2019.10433. Epub 2019 Jun 4.
6
A Simple Fecal Bacterial Marker Panel for the Diagnosis of Crohn's Disease.一种用于诊断克罗恩病的简单粪便细菌标志物组合
Front Microbiol. 2019 Jun 12;10:1306. doi: 10.3389/fmicb.2019.01306. eCollection 2019.
7
Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity.具核梭杆菌通过诱导炎症和抑制宿主免疫促进结直肠癌的发生。
Transl Oncol. 2019 Jun;12(6):846-851. doi: 10.1016/j.tranon.2019.03.003. Epub 2019 Apr 12.
8
in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review.在胃肠癌中:使用定量聚合酶链反应的测量方法评估及文献综述
Oncol Lett. 2017 Dec;14(6):6373-6378. doi: 10.3892/ol.2017.7001. Epub 2017 Sep 19.
9
Quantitation of faecal improves faecal immunochemical test in detecting advanced colorectal neoplasia.粪便定量检测可提高粪便免疫化学检测对晚期结直肠肿瘤的检测能力。
Gut. 2017 Aug;66(8):1441-1448. doi: 10.1136/gutjnl-2016-312766. Epub 2016 Oct 24.
10
Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.抗具核梭杆菌抗体水平在结直肠癌血清学诊断中的评估
Sci Rep. 2016 Sep 28;6:33440. doi: 10.1038/srep33440.